New acquisition poised to strengthen TopGum's position as one of the leading CDMOs in the gummy supplement industry with annual revenue rate in excess of USD 100 million TopGum Industries, Ltd. (TASE: TPGM), a global leader in the development and manufacturing of gummy supplements, announces it has acquired Island Abbey Nutritionals™, a leading CDMO specializing […]
Seeks to expand regulatory approval in China where IceSense3 has already been approved IceCure Medical Ltd. (Nasdaq: ICCM) (“IceCure”, “IceCure Medical” or the “Company”), developer of minimally-invasive cryoablation technology that destroys tumors by freezing as an alternative to surgical tumor removal, today announced it has submitted a regulatory filing with China's National Medical Products Administration
Ostro, a leader in AI-driven digital engagement solutions, is proud to spotlight its partnership with the Desmoid Tumor Research Foundation (DTRF) as we approach Rare Disease Month, a meaningful time to foster awareness and champion impactful innovation. This collaboration brings Ostro's cutting-edge, AI-powered engagement capabilities pro bono to the DTRF website, significantly enhancing access to
Precision Products Group (“PPG”), an Auxo Investment Partners portfolio company, announced today the acquisition of Cindus Corporation, a Cincinnati, Ohio-based manufacturer of crepe paper for electrical and industrial applications. https://mma.prnewswire.com/media/2089920/Auxo_Logo.jpg PPG's acquisition of Cindus will strengthen its position as a key supplier of insulation materials to the rapidly expanding electrical transformer market. It will also
Broadway Financial Corporation (“Broadway” or the “Company”) (NASDAQ: BYFC), parent company of City First Bank, National Association (the “Bank”, and collectively with the Company, “we” or “City First Broadway”), reported net income attributable to Broadway of $1.3 million for the fourth quarter of 2024 compared to $2.6 million for the fourth quarter of 2023, a
Walter Klemp, CEO of Moleculin, provides an update on the Company's Phase 3 pivotal trial of Annamycin for the treatment of AML patients who are refractory to or relapsed after induction therapy (R/R AML) (the “MIRACLE” trial) Watch the “What This Means” segment here Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), a late-stage
CIBC (TSX: CM) (NYSE: CM) – CIBC Asset Management Inc. today announced the January 2025 cash distributions for CIBC ETFs and ETF Series of the CIBC Fixed Income Pools, which distribute monthly. Unitholders of record on January 31, 2025, will receive cash distributions payable on February5, 2025. Details of the final “per unit” distribution amounts
(NASDAQ:ALCO), FORT MYERS, Fla., Jan. 27, 2025 (GLOBE NEWSWIRE) — Alico, Inc. (“Alico” or the “Company”) (Nasdaq: ALCO) today announced that John Kiernan, the Company's President and Chief Executive Officer, will present and host one-on-one meetings with investors at The Microcap Conference 2025, the premier event for growth-focused companies and investors. The conference will take
Singapore , Jan. 27, 2025 (GLOBE NEWSWIRE) — The cryptocurrency community has been buzzing ever since JuCoin, a leading service-driven crypto exchange, kicked off its Initial Exchange Offering (IEO) for the $JU token. What started as a standard IEO quickly turned into a remarkable success story, reflecting the immense demand for the $JU token and
(NASDAQ:SGBX), MIAMI, FL, Jan. 27, 2025 (GLOBE NEWSWIRE) — Safe & Green Holdings Corp. (NASDAQ: SGBX) (“Safe & Green Holdings” or the “Company”), a leading developer, designer, and fabricator of modular structures, today announced it has entered into a Securities Purchase Agreement with Alumni Capital LP, establishing an equity line of credit (ELOC). This agreement